Skip to main content
Starting at $149/month • ✓ Licensed Providers
Naples-based telehealth · Southwest Florida · Florida · 47 of 50 U.S. states (excluding AK, HI, and AR) · No walk-in address · Call 239-422-6350 · Book Online
Medically Reviewed

Clinical content on this page follows South Florida Trim Clinic's editorial process for factual accuracy and alignment with current Tirzepatide & GIP/GLP-1 Dual-Agonist Therapy standards. This content is for educational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment. Full provider credentials are disclosed to enrolled patients. Medical Editorial Policy

Last medically reviewed: June 2026Content updated: July 2026

Tirzepatide Weight Loss

Tirzepatide Weight Loss in Florida

Tirzepatide is a dual agonist medication that targets two biological pathways associated with appetite and blood sugar — GLP-1 and GIP. South Florida Trim Clinic offers licensed-provider-reviewed tirzepatide consultations for qualifying patients across Florida and 47 of the 50 U.S. states, excluding Alaska, Hawaii, and Arkansas.

Medical eligibility required. A provider must determine whether treatment is right for you.

What Makes Tirzepatide Different
Dual Action
Targets both GLP-1 and GIP receptors — two separate appetite-regulating pathways
Once-Weekly
Administered once weekly by subcutaneous injection, if prescribed
Provider-Supervised
Every patient receives full provider review and ongoing oversight

Quick answer

What is tirzepatide weight loss?

Tirzepatide is a dual-action (GIP and GLP-1) medication that may support weight loss by reducing appetite and food noise for eligible patients. South Florida Trim Clinic helps Florida patients explore licensed-provider-reviewed tirzepatide support through affordable telehealth, with eligibility decided after medical review. Results vary, and this information is educational and not a substitute for medical advice.

What Is Tirzepatide?

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. While semaglutide works on a single GLP-1 pathway, tirzepatide activates two separate hormone pathways simultaneously — GLP-1 and GIP — both of which are involved in regulating appetite, blood sugar, and metabolism.

Tirzepatide is the active ingredient in Mounjaro® (approved for type 2 diabetes) and Zepbound® (approved for chronic weight management in adults with obesity or weight-related conditions). It is administered once weekly as a subcutaneous injection.

Important: Tirzepatide is not appropriate for everyone. Not every patient qualifies, and a provider must review your full health history, current medications, and clinical eligibility before any prescription is issued. Side effects and contraindications must be reviewed.

How Tirzepatide Supports Weight Loss

By acting on both the GLP-1 and GIP receptors, tirzepatide produces several overlapping effects that may support weight reduction in eligible patients:

Dual Receptor Activation
GIP and GLP-1 receptors each play a role in appetite regulation and metabolic signaling. Tirzepatide engages both, which may produce broader effects than single-pathway medications.
Appetite Pathways
Tirzepatide acts on pathways involved in hunger and food preoccupation; a provider can discuss likely effects and limitations.
Slowed Gastric Emptying
Like semaglutide, tirzepatide slows how quickly food moves through the stomach, supporting a longer feeling of fullness after meals.
Blood Sugar Management
Originally developed for type 2 diabetes, tirzepatide has strong effects on insulin secretion and blood sugar regulation — reducing the crashes that often trigger cravings.
Progressive Titration
Your provider will start you at the lowest effective dose and titrate upward over weeks to months, balancing efficacy and tolerability.

Semaglutide vs. Tirzepatide: Which Is Right for You?

Both semaglutide and tirzepatide are GLP-1 receptor agonists. The key difference is that tirzepatide also acts on GIP receptors — a second pathway. Both are administered once weekly. Both require medical supervision and provider-determined eligibility.

The right medication for you depends on your health history, any concurrent conditions like type 2 diabetes, your provider's clinical assessment, and individual response to treatment. Your South Florida Trim Clinic provider will evaluate all of these factors during your consultation.

We don't push one medication over another. We help you understand your options and let your provider make a recommendation based on your specific situation. Results vary, and medication may be one part of a broader weight-management plan.

Tirzepatide Consultations at South Florida Trim Clinic

Our telehealth practice started in Naples, Florida and now serves eligible patients in 47 of the 50 U.S. states, excluding Alaska, Hawaii, and Arkansas. Every tirzepatide patient receives a provider consultation, clinical review, dosage management, and ongoing support.

We do not make money from celebrity endorsements. We don't have a luxury headquarters. Every dollar we save goes toward keeping your care accessible. Ask us about pricing for tirzepatide — our team will walk you through every cost transparently.

Licensed providers evaluate every patient individually
Medication sourced from FDA-regulated pharmacies when prescribed
Ongoing dosage adjustments and provider access
100% telehealth — in 47 of 50 states (excluding AK, HI, AR)
No bundled spa services. No upsells. Just weight loss care.

Frequently Asked Questions

What is tirzepatide and how does it work for weight loss?+

Tirzepatide is a dual GLP-1 and GIP receptor agonist, meaning it activates two separate hormone pathways involved in appetite, blood sugar, and metabolism. It is the active ingredient in Mounjaro® (for type 2 diabetes) and Zepbound® (for chronic weight management). For eligible patients, tirzepatide may reduce appetite, slow gastric emptying, and ease the 'food noise' many people describe. It is administered once weekly under medical supervision, and a licensed provider must determine whether it is appropriate. Results vary and not everyone qualifies.

Who may qualify for tirzepatide?+

Eligibility is determined by a licensed provider after reviewing your health history, current medications, and goals. Tirzepatide is typically considered for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as type 2 diabetes or high blood pressure. Not everyone qualifies, and your provider will review risks, benefits, and alternatives before any prescription is issued. Telehealth availability may vary by state and patient eligibility.

What are the common side effects of tirzepatide?+

Common side effects can include nausea, vomiting, diarrhea, constipation, and fatigue, especially during the early dose-titration period. These often improve as your body adjusts. Tirzepatide is not appropriate for everyone, and certain conditions may make treatment inappropriate. You should review all potential side effects, contraindications, risks, and alternatives with a licensed clinician before starting. Your provider monitors your response and can adjust your plan. Results vary from patient to patient.

Is tirzepatide more effective than semaglutide?+

Tirzepatide and semaglutide work somewhat differently — tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1 alone. Individual results vary, and the better option for you depends on your health history, any conditions like type 2 diabetes, tolerability, and your provider's clinical judgment. We do not push one medication over another. Your provider will help you weigh semaglutide vs. tirzepatide and recommend an approach for your situation. Eligibility is determined by a licensed provider.

How quickly does tirzepatide work?+

Results vary based on starting weight, dose, adherence, lifestyle, and individual response. Your provider starts you at the lowest effective dose and titrates upward over weeks to months to balance effectiveness and tolerability. Appetite and weight changes may develop gradually over several months. Tirzepatide may be one part of a broader plan that includes nutrition, activity, and ongoing medical support. There are no guaranteed outcomes.

How much does tirzepatide cost and is telehealth available?+

South Florida Trim Clinic provides licensed-provider-reviewed tirzepatide consultations via telehealth for eligible patients in 47 of the 50 U.S. states, excluding Alaska, Hawaii, and Arkansas. Our team explains tirzepatide pricing transparently, and medication ships from regulated pharmacies when prescribed and medically appropriate. Final costs depend on the plan your provider recommends.

Clinical References & Sources

The following authoritative sources were referenced in preparing this educational content. All references are publicly available and verifiable.

  1. Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." N Engl J Med. 2022;387:205–216. [SURMOUNT-1 Trial] doi:10.1056/NEJMoa2206038
  2. Frías JP, et al. "Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes." N Engl J Med. 2021;385:503–515. [SURPASS-2 Trial] doi:10.1056/NEJMoa2107519
  3. U.S. Food & Drug Administration. "Highlights of Prescribing Information: Zepbound (tirzepatide) injection." Eli Lilly. 2023. FDA prescribing information
  4. U.S. Food & Drug Administration. "FDA Approves New Medication for Chronic Weight Management." November 8, 2023. fda.gov
  5. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). "Prescription Medications to Treat Overweight & Obesity." niddk.nih.gov

Last reviewed: June 2026 · Medical content is for educational purposes only and is not a substitute for professional medical advice.

Find Out If Tirzepatide Is Right for You

Book a free consultation with a licensed South Florida Trim Clinic provider. Honest answers. No pressure.

Medical eligibility required. Side effects and contraindications must be reviewed. Results vary.